Lakafin (Tioconazole)

Tioconazole works by inhibiting the fungal enzyme lanosterol 14α‑demethylase, which is essential for the synthesis of ergosterol, a key component of fungal cell membranes. Disruption of ergosterol production compromises membrane integrity, leading to leakage of cellular contents and inhibition of fungal growth at the site of application.

The specific dosing regimen for Lakafin is determined by the prescribing healthcare professional based on the type and severity of the infection. Typically, a thin layer of the cream is applied to the affected area once or twice daily for the duration recommended by the prescriber. Patients should follow the instructions provided on the label or by their clinician.

Safety data for Tioconazole use during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential risks and benefits with their healthcare provider before using Lakafin. The prescriber can decide whether an alternative therapy is more appropriate.

To order Lakafin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Lakafin’s active ingredient, Tioconazole, belongs to the imidazole class and offers a broad spectrum against dermatophytes and Candida species. Compared with allylamine agents such as terbinafine, imidazoles may have a slightly slower onset but are effective for both dermatophyte and yeast infections. The topical route limits systemic exposure, making it a convenient option for localized skin infections.

Lakafin should be stored at room temperature, preferably below 25 °C, in its original container. Keep the product away from direct sunlight, moisture and heat sources. Ensure the cap is tightly closed after each use to maintain product stability. Do not freeze the cream, and keep it out of reach of children.

Before applying Lakafin, wash and gently dry the affected area. Apply a thin layer of the cream to the lesion and the surrounding skin, gently massaging it in until fully absorbed. Wash your hands after application unless the hands are the treatment site. Use the product for the duration prescribed, even if symptoms improve earlier.

Serious adverse reactions, although rare, include severe allergic responses such as hives, swelling, contact dermatitis, angioedema and anaphylaxis. If any signs of a systemic allergic reaction occur—such as difficulty breathing, facial swelling or widespread rash—stop using the product immediately and seek emergency medical attention.

Lakafin should not be used by individuals with a known hypersensitivity to Tioconazole or any other imidazole antifungal. It is also contraindicated on broken, severely inflamed or infected skin where the barrier is compromised. Patients with a history of severe allergic reactions to topical medications should consult a healthcare professional before using Lakafin.